Rhumbline Advisers »

C4 Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $10k 1.8k 5.65
2023-09-30 $3.3k 1.8k 1.86
2023-06-30 $11k 4.0k 2.75
2023-03-31 $211k 67k 3.15
2022-12-31 $379k 64k 5.89
2022-09-30 $562k 64k 8.78
2022-06-30 $453k 60k 7.54
2022-03-31 $987k 41k 24.25
2021-12-31 $1.2M 38k 32.19
2021-09-30 $1.7M 38k 44.69
2021-06-30 $1.3M 35k 37.84
2021-03-31 $380k 10k 36.96
2020-12-31 $285k 8.6k 33.17